CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 8-K Event Shareholder vote results
- 4 Option exercise Chief Legal Officer acquired 27,595 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 43,248 shares at $11.22 ($485,221)
- 4 Derivatives Options or other derivatives
- 4 Grant or award VP of Finance and Controller acquired 4,848 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K/A Event Executive or director change
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
Page 11 of 17 · 326 filings